SOLS — Solstice Advanced Materials Inc.

Summary of Solstice Advanced Materials Inc. Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Full Year 2025 Results:

  • Net Sales: $3.9 billion, up 3% YoY (6% excluding opportunistic nuclear sales in 2024).
  • Adjusted Standalone EBITDA: $957 million, down 4% YoY; EBITDA margin: 24.6%.
  • Net Income: $237 million, impacted by higher tax expenses and interest costs post-spin-off.

• Q4 2025 Results:

  • Net Sales: $987 million, up 8% YoY.
  • Adjusted Standalone EBITDA: $189 million, down 20% YoY; EBITDA margin: 19.1%.
  • Net Income: $41 million, affected by increased interest expense and non-controlling interest.

2. Strategic Updates and Business Highlights

• Transitioned to an independent public company post-spin-off from Honeywell on October 30, 2025.
• Strong operational execution and demand in sectors like nuclear energy, AI, and data centers.
• Announced plans to double sputtering target capacity in Spokane and expand nuclear conversion capacity.
• Initiated a quarterly dividend of $0.75 per share, marking a commitment to return capital to shareholders.
• Significant backlog in the nuclear business exceeding $2 billion, with expectations of 20% production increase in 2026.

3. Forward Guidance and Outlook

• 2026 Guidance:
  • Expected Net Sales: $3.9 billion to $4.1 billion.
  • Adjusted EBITDA: $975 million to $1.025 billion.
  • Adjusted EPS: $2.45 to $2.75.
  • Anticipated capital expenditures: $400 million to $425 million.
• Q1 2026 Guidance:
  • Expected Net Sales: $935 million to $985 million.
  • Adjusted EBITDA: $235 million to $245 million, implying a margin of approximately 25%.

4. Bad News, Challenges, or Points of Concern

• Adjusted EBITDA for 2025 decreased primarily due to transitory costs and the ongoing transition to low global warming potential refrigerants.
• Anticipated $30 million revenue impact from the final return of nuclear product loans in 2026, which is expected to affect sales volume.
• The decline in net income for both the full year and Q4 due to higher tax expenses and interest costs.
• Challenges in the healthcare packaging segment, which saw a 25% decline in net sales due to customer destocking.

5. Notable Q&A Insights

• Nuclear Business: Pricing is expected to improve incrementally as contracts align with rising spot prices, with a backlog that supports double-digit EBITDA growth through 2030.
• Refrigerant Transition: The company is transitioning from HFCs to HFOs, expecting an 80-20 split by 2026. Short-term margin impacts are anticipated due to the mix shift.
• Data Center Growth: Strong demand in data centers is noted, with the company addressing this through multiple business segments.
• M&A Strategy: The company is developing a robust M&A pipeline and is open to pursuing attractive opportunities that align with its strategic goals.

Overall, Solstice Advanced Materials Inc. demonstrated resilience and growth potential in Q4 2025, despite facing challenges related to transitions in product lines and external market conditions. The company is strategically positioned for future growth with a strong focus on high-return investments and shareholder returns.